Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
27.5M
-
Number of holders
-
48
-
Total 13F shares, excl. options
-
14.5M
-
Shares change
-
+643K
-
Total reported value, excl. options
-
$108M
-
Value change
-
+$5.06M
-
Number of buys
-
24
-
Number of sells
-
-19
-
Price
-
$7.45
Significant Holders of FENNEC PHARMACEUTICALS INC. - Common Shares, no par value (FENC) as of Q4 2020
60 filings reported holding FENC - FENNEC PHARMACEUTICALS INC. - Common Shares, no par value as of Q4 2020.
FENNEC PHARMACEUTICALS INC. - Common Shares, no par value (FENC) has 48 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 14.5M shares
of 27.5M outstanding shares and own 52.69% of the company stock.
Largest 10 shareholders include Southpoint Capital Advisors LP (4.08M shares), Sonic Fund II, L.P. (2.43M shares), Avoro Capital Advisors LLC (1.67M shares), EVENTIDE ASSET MANAGEMENT, LLC (1.12M shares), 683 Capital Management, LLC (1.11M shares), BlackRock Inc. (1.11M shares), Solas Capital Management, LLC (800K shares), GRANAHAN INVESTMENT MANAGEMENT INC/MA (395K shares), STATE STREET CORP (341K shares), and Russell Investments Group, Ltd. (218K shares).
This table shows the top 48 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.